Third Point’s Gilead Sciences GILD Stock Holding History

Third Point’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-128,000	Closed	-$257K	–	40
2013 Q2	$257K	Buy	+128,000	New	+$6.67M	0.01%	30

Other funds holding GILD

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Third Point's GILD Position: Q1 2014 in Review

Third Point sold out of Gilead Sciences (GILD) in Q1 2014, closing a stake of 1,500,000 shares — an estimated $113M sold.

Third Point first reported a position in GILD in Q3 2013 and held it in 2 quarters. The position peaked at $113M in Q4 2013. 1,188 funds tracked by Wall St. Rank hold GILD as of Q1 2014.

Third Point reported no remaining Gilead Sciences position as of Q1 2014 after selling out during the quarter.
Third Point sold 1,500,000 Gilead Sciences shares in Q1 2014, an estimated $113M.
Third Point first reported a position in Gilead Sciences in Q3 2013 and held it in 2 quarters.
Third Point's Gilead Sciences position peaked at $113M in Q4 2013.
1,188 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2014.

Based on Third Point's 13F filing for Q1 2014, filed 15 May 2014.